Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

77
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
77
Allergic Reactions02:06

Allergic Reactions

32.7K
Overview
32.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dupilumab Extended Interval Dosing in Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review and Meta-analysis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Mupirocin Nasal Irrigation Following Endoscopic Sinus Surgery: A Prospective, Double-Blinded, Placebo-Controlled Trial.

American journal of rhinology & allergy·2026
Same author

Psychological Capital and Work Engagement Among Mental Health Nurses in Saudi Arabia: The Mediation Role of Motivation at Work.

Journal of nursing management·2026
Same author

Assessment of practice and barriers to lifestyle medicine among physicians in Saudi Arabia-A cross-sectional study.

Journal of family medicine and primary care·2026
Same author

External Cervical Resorption Secondary to Orthodontic Treatment in a Previously Traumatized Tooth: A Case Report.

Cureus·2026
Same author

Characteristic and Clinical Outcomes of Localized Gastric Cancer: A Real-World Experience.

Hematology/oncology and stem cell therapy·2026

Related Experiment Video

Updated: Mar 1, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K

House Dust Mite Sublingual Immunotherapy for Allergic Rhinoconjunctivitis: Comprehensive Review and Meta-Analytical

Abdulsalam Alqutub1, Abdulelah G Abumohssin2, Sulafa T Alqutub3

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Makkah Health Cluster, Makkah, Saudi Arabia, ksasalam47@gmail.com.

International Archives of Allergy and Immunology
|February 27, 2026
PubMed
Summary
This summary is machine-generated.

Sublingual immunotherapy (SLIT) effectively reduces symptoms and medication use in adults and adolescents with house dust mite (HDM)-induced allergic rhinoconjunctivitis (ARC). This disease-modifying therapy demonstrates a favorable safety profile, supporting its use in managing HDM allergies.

Keywords:
Allergic rhinitisAllergic rhinoconjunctivitisHouse dust miteMeta-analysisSublingual immunotherapy

More Related Videos

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.7K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.6K

Related Experiment Videos

Last Updated: Mar 1, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.7K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.6K

Area of Science:

  • Allergy and Immunology
  • Clinical Medicine
  • Pharmacology

Background:

  • House dust mites (HDM) are a major trigger for allergic rhinoconjunctivitis (ARC), significantly impacting quality of life.
  • Sublingual immunotherapy (SLIT) using HDM extracts shows promise for ARC treatment, but its efficacy and safety in adults and adolescents require further definition.

Purpose of the Study:

  • To systematically evaluate the efficacy and safety of HDM SLIT in adults and adolescents diagnosed with ARC.

Main Methods:

  • A systematic literature search was conducted across major databases (PubMed, Scopus, Web of Science, Cochrane CENTRAL) up to May 2025.
  • Included studies compared HDM SLIT against placebo or pharmacotherapy, analyzing key efficacy outcomes like symptom and medication scores (CSMS, RSS, RMS) and quality of life (RQLQ).
  • Safety was assessed through treatment-related adverse events (AEs), with data pooled using random-effects models for standardized mean differences (SMD) and risk ratios (RR).

Main Results:

  • The meta-analysis included data from 28 of 45 reviewed studies (30,288 participants).
  • HDM SLIT significantly improved rhinitis symptom score (RSS) and rhinitis medication score (RMS) (SMD: -0.98 and -1.00, respectively).
  • A higher incidence of treatment-related adverse events (AEs) was observed with SLIT (RR: 1.16), though these were predominantly mild, local, and transient.

Conclusions:

  • Standardized HDM SLIT is confirmed as an effective, disease-modifying therapy for adults and adolescents with ARC.
  • SLIT offers clinically significant reductions in symptoms and medication requirements, alongside improvements in quality of life.
  • The favorable safety profile supports HDM SLIT as a foundational treatment for managing HDM-induced ARC.